<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-64368</identifier>
<setSpec>0210-5691</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:description xml:lang="en">ST segment elevation acute coronary syndrome is a clinical condition that is rarely observed in pregnant women. However, its manifestation is a situation of high maternal-fetal risk. Pharmacotherapeutical management of these patients is difficult and requires individualized care by a multidisciplinary team since many of the standard treatments are included within the categories of teratogencity C or D of the Food and Drug Administration and experience with techniques such as coronary angioplasty with stent placement is scarce. The case of a 32-year woman who was 11 weeks pregnant and diagnosed of acute coronary syndrome with ST segment and its therapeutic approach are described. Furthermore, the information available on epidemiology, etiology and pathophysiology of acute coronary syndrome with ST segment during pregnancy and the specific role of the currently available treatment options are reviewed</dc:description>
<dc:creator>González de la Rosa, J</dc:creator>
<dc:creator>Llinares Tello, F</dc:creator>
<dc:creator>Bosacoma Ros, N</dc:creator>
<dc:creator>Ordovás Baines, J. P</dc:creator>
<dc:creator>Ortolá Vercher, V</dc:creator>
<dc:creator>Hernández Prats, C</dc:creator>
<dc:creator>Caturla Such, J. M</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">El síndrome coronario agudo con elevación de ST (SCACEST) es una entidad clínica que rara vez se observa en mujeres embarazadas, pero cuya manifestación constituye una situación de alto riesgo materno-fetal. El manejo farmacoterapéutico de estas pacientes es difícil y requiere una atención individualizada por parte de un equipo multidisciplinar, puesto que muchos de los tratamientos estándar se incluyen dentro de las categorías de teratogenicidad C o D de la Food and Drug Administration, y es escasa la experiencia con técnicas como la angioplastia coronaria con colocación de stent. Se describe el caso de una mujer de 32 años, gestante de 11 semanas y diagnosticada de SCACEST, así como el abordaje terapéutico de la misma. Además se revisa la información disponible sobre la epidemiología, etiología y fisiopatología del SCACEST durante el embarazo y el papel específico de las opciones de tratamiento disponibles actualmente</dc:description>
<dc:source>Med. intensiva (Madr., Ed. impr.);31(1): 29-35, ene. 2007. ilus</dc:source>
<dc:identifier>ibc-64368</dc:identifier>
<dc:subject>^d22261</dc:subject>
<dc:subject>^d5453</dc:subject>
<dc:subject>^d28612</dc:subject>
<dc:subject>^d24892^s22074</dc:subject>
<dc:subject>^d1150^s22012</dc:subject>
<dc:subject>^d35526</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d3343^s22057</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d30178^s22074</dc:subject>
<dc:subject>^d11689^s22057</dc:subject>
<dc:subject>^d32069</dc:subject>
<dc:type>article</dc:type>
<dc:date>200701</dc:date>
</metadata>
</record>
</ibecs-document>
